December 2020 Quarterly Update – 22 January 2021
PainChek receives regulatory clearance from Health Canada – 19 November 2020
PainChek® to enter Canadian homecare market in partnership with AlayaCare – 28 October 2020
Confirmation of Release – PCK – PainChek Granted Patent in China – 14 August 2020
PainChek completes $10 million Placement – 11 August 2020
June 2020 Quarterly Update – 28 July 2020
Appendix 4E Preliminary Final Report to the Australian Securities Exchange – 30 June 2020
PainChek® plans Canadian regulatory clearance and market entry – 10 June 2020
PainChek® granted Australian patent for pain assessment invention – 8th May 2020
Appendix 4C – Quarterly cash flow report for entities subject to Listing Rule 4.7B – 31 March 2020
PainChek® submits FDA Pre-Submission Supplement- 14 April 2020
Coronavirus: Impact minimised by PCK’s digital business model – 12 March 202
PainChek® secures Japanese patent, progressing global expansion – 15 January 2020
Update on PainChek® business performance – 23 December 2019
PainChek® UK confirms first orders, expands presence in the UK market – 3 December 2019
Appendix 4C – Quarterly report for entities subject to Listing Rule 4.7B – 30 September 2019
PainChek® receives Singapore regulatory clearance 6 August 2019